Bright Minds Biosciences (DRUG) Cash from Operations: 2019-2024
Historic Cash from Operations for Bright Minds Biosciences (DRUG) over the last 6 years, with Sep 2024 value amounting to -$1.4 million.
- Bright Minds Biosciences' Cash from Operations fell 3441.42% to -$9.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$5.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.4 million for FY2024, which is 73.89% up from last year.
- According to the latest figures from FY2024, Bright Minds Biosciences' Cash from Operations is -$1.4 million, which was up 73.89% from -$5.2 million recorded in FY2023.
- In the past 5 years, Bright Minds Biosciences' Cash from Operations registered a high of -$214,556 during FY2020, and its lowest value of -$10.6 million during FY2022.
- For the 3-year period, Bright Minds Biosciences' Cash from Operations averaged around -$5.7 million, with its median value being -$5.2 million (2023).
- As far as peak fluctuations go, Bright Minds Biosciences' Cash from Operations slumped by 2,599.19% in 2021, and later skyrocketed by 73.89% in 2024.
- Bright Minds Biosciences' Cash from Operations (Yearly) stood at -$214,556 in 2020, then crashed by 2,599.19% to -$5.8 million in 2021, then plummeted by 83.78% to -$10.6 million in 2022, then soared by 51.05% to -$5.2 million in 2023, then soared by 73.89% to -$1.4 million in 2024.